BrainStorm

March 31, 2014

How Close Are We to an Approved Treatment? - Bernard Munos

Thumbnail

How Close Are We to an Approved Treatment? - Bernard Munos

About This Episode

A discussion with Bernard Munos, Founder of InnoThink, and named one of the 25 most influential people in biopharma by FiercePharma.  He discussed his analysis of the drug pipeline, the status of drugs in it, as well as his recommendations for how we can organize research more effectively and lower the cost of innovation and reduce the risk of failure so that we can get to a cure faster and at lower cost.

This call was made possible by the generous support of the Zickler Family Foundation.

BrainStorm Feed

80
February 18, 2025 | 22:39

George Vradenburg and the Global Impact of Alzheimer's (part 1)

Alzheimer’s is not just an aging issue, but a lifelong brain health challenge that has major global, economic, and societal implications.

LISTEN NOW
79
February 4, 2025 | 17:27

Rudy Tanzi – Alzheimer’s Updates and Developments; What’s New? (part 2)

In this episode of BrainStorm host Meryl Comer continues her compelling interview with "Rockstar of Science" Dr.

LISTEN NOW
78
January 21, 2025 | 18:09

Dr. Rudy Tanzi - Alzheimer's Updates and Developments; What's New for 2025?

Join BrainStorm host Meryl Comer as she kicks off 2025 with "Rockstar of Science" Dr.

LISTEN NOW